Most men see a doctor reactively — something hurts, something broke, something alarming appeared. The annual blood panel is the antidote to that pattern: a systematic snapshot of the systems that matter most, ordered before symptoms force the conversation.

What follows is not the standard "get a CBC and a lipid panel" advice. This is the expanded menu for men who want to catch problems early and track optimization metrics — organized by age bracket because priorities shift every decade.

The Universal Baseline (All Ages)

Every man, every year, regardless of age or medication status:

TestWhat It CatchesWhy Men Skip It
CBC (Complete Blood Count)Anemia, infection, polycythemia (critical on TRT)Feels "basic" — but hematocrit alone justifies it
CMP (Comprehensive Metabolic Panel)Kidney function, liver enzymes, glucose, electrolytesUsually included with any panel
Lipid PanelCardiovascular risk (total cholesterol, LDL, HDL, triglycerides)No symptoms until it's a crisis
HbA1c3-month average blood sugar, pre-diabetes screeningMen assume diabetes is obvious
TSHThyroid function — affects weight, energy, moodThyroid disease is "a women's thing" (it isn't)

Your 20s: The Baseline Decade

In your twenties, the goal isn't optimization — it's documentation. Establish your baseline for testosterone, metabolic markers, and thyroid function while your body is presumably at peak function. These numbers become the reference point against which future changes are measured.

Add to baseline:

What you probably don't need at this age: PSA screening, advanced cardiac markers, or inflammatory panels — unless family history dictates otherwise.

Your 30s: The Transition Decade

Testosterone begins its roughly 1–2% annual decline after 30. Metabolic changes from career sedentarism and dietary habits start showing up in bloodwork before they show up in the mirror.

Add to baseline:

Your 40s: The Monitoring Decade

This is when most men's health stacks start. GLP-1 prescriptions peak in the 40–55 age range. TRT initiation concentrates between 40 and 50. The lab panel needs to expand to cover everything these therapies affect.

Add to baseline:

Your 50s: The Cardiovascular Decade

Cardiovascular risk rises substantially. The TRAVERSE trial (2023) provided reassurance that TRT doesn't increase major adverse cardiac events, but the 50s is when underlying vascular disease manifests regardless of TRT status.

Add to baseline:

Your 60s and Beyond: The Comprehensive Decade

At 60+, the lab panel is essentially the full menu. Everything above, plus heightened attention to markers that predict age-related decline:

Lab Timing for Men on Medications

When to Draw Based on Your Stack

The Bottom Line

Build Your Panel by Decade

Start with the universal baseline, add decade-specific markers, and layer in medication-monitoring tests as your stack evolves. The goal is a single comprehensive draw that covers everything — not three separate panels ordered by three separate providers who don't talk to each other.